Will sparsentan prove a winner for patients with FSGS, or are we doomed to forever treat them with Acthar Gel? We've all been guilted into ordering inpatient blood pressure meds. Tim Anderson, MD, asks, "Why?" What can the Gila monster and mourning dove teach us about comparative nephrology?